These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8748120)

  • 1. Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function.
    Montkowski A; Barden N; Wotjak C; Stec I; Ganster J; Meaney M; Engelmann M; Reul JM; Landgraf R; Holsboer F
    J Neuroendocrinol; 1995 Nov; 7(11):841-5. PubMed ID: 8748120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the monoamine oxidase A inhibitor moclobemide on hippocampal plasticity in GR-impaired transgenic mice.
    Steckler T; Rammes G; Sauvage M; van Gaalen MM; Weis C; Zieglgänsberger W; Holsboer F
    J Psychiatr Res; 2001; 35(1):29-42. PubMed ID: 11287054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced morphine-induced behavioural effects and dopamine release in the nucleus accumbens in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: influence of long-term treatment with the antidepressant moclobemide.
    Sillaber I; Montkowski A; Landgraf R; Barden N; Holsboer F; Spanagel R
    Neuroscience; 1998 Jul; 85(2):415-25. PubMed ID: 9622241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide.
    Reul JM; Labeur MS; Grigoriadis DE; De Souza EB; Holsboer F
    Neuroendocrinology; 1994 Nov; 60(5):509-19. PubMed ID: 7845541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid receptor impairment alters CNS responses to a psychological stressor: an in vivo microdialysis study in transgenic mice.
    Linthorst AC; Flachskamm C; Barden N; Holsboer F; Reul JM
    Eur J Neurosci; 2000 Jan; 12(1):283-91. PubMed ID: 10651883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of corticosteroid receptor gene expression in depression and antidepressant action.
    Barden N
    J Psychiatry Neurosci; 1999 Jan; 24(1):25-39. PubMed ID: 9987205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor.
    Barden N; Stec IS; Montkowski A; Holsboer F; Reul JM
    Neuroendocrinology; 1997 Sep; 66(3):212-20. PubMed ID: 9380279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant action of agomelatine (S 20098) in a transgenic mouse model.
    Barden N; Shink E; Labbé M; Vacher R; Rochford J; Mocaër E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):908-16. PubMed ID: 16005135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function.
    Karanth S; Linthorst AC; Stalla GK; Barden N; Holsboer F; Reul JM
    Endocrinology; 1997 Aug; 138(8):3476-85. PubMed ID: 9231802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cAMP-dependent phosphorylation system after short and long-term administration of moclobemide.
    Mori S; Zanardi R; Popoli M; Garbini S; Brunello N; Smeraldi E; Racagni G; Perez J
    J Psychiatr Res; 1998; 32(2):111-5. PubMed ID: 9694007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of moclobemide on the yohimbine-induced anxiogenic action in the elevated plus-maze.
    Eroğlu L; Güven O
    Pharmacol Res; 1998 Feb; 37(2):137-43. PubMed ID: 9572069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpressing the glucocorticoid receptor in forebrain causes an aging-like neuroendocrine phenotype and mild cognitive dysfunction.
    Wei Q; Hebda-Bauer EK; Pletsch A; Luo J; Hoversten MT; Osetek AJ; Evans SJ; Watson SJ; Seasholtz AF; Akil H
    J Neurosci; 2007 Aug; 27(33):8836-44. PubMed ID: 17699665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of glucocorticoid receptor gene expression by antidepressant drugs.
    Barden N
    Pharmacopsychiatry; 1996 Jan; 29(1):12-22. PubMed ID: 8852529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of moclobemide on forced-swimming stress and brain monoamine levels in mice.
    Miura H; Naoi M; Nakahara D; Ohta T; Nagatsu T
    Pharmacol Biochem Behav; 1996 Feb; 53(2):469-75. PubMed ID: 8808160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moclobemide effects on prolactin plasma levels in healthy individuals: the hormonal increase induced by a single dose is maintained during a 4-week period of drug intake.
    Juruena MF; Pires ML; Calil HM
    Int Clin Psychopharmacol; 1997 Nov; 12(6):317-21. PubMed ID: 9547133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental anxiety and antidepressant drugs: the effects of moclobemide, a selective reversible MAO-A inhibitor, fluoxetine and imipramine in mice.
    de Angelis L
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):379-83. PubMed ID: 8878071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural toxicity of antidepressants with particular reference to moclobemide.
    Hindmarch I; Kerr J
    Psychopharmacology (Berl); 1992; 106 Suppl():S49-55. PubMed ID: 1546141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired glucocorticoid receptor function evolves in aberrant physiological responses to bacterial endotoxin.
    Linthorst AC; Karanth S; Barden N; Holsboer F; Reul MH
    Eur J Neurosci; 1999 Jan; 11(1):178-86. PubMed ID: 9987022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial memory in transgenic mice with impaired glucocorticoid receptor function.
    Rousse I; Beaulieu S; Rowe W; Meaney MJ; Barden N; Rochford J
    Neuroreport; 1997 Mar; 8(4):841-5. PubMed ID: 9141049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
    Nikisch G
    Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.